Literature DB >> 17170065

Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Jose A Rodríguez-Gómez1, Jian-Qiang Lu, Iván Velasco, Seth Rivera, Sami S Zoghbi, Jeih-San Liow, John L Musachio, Frederick T Chin, Hiroshi Toyama, Jurgen Seidel, Michael V Green, Panayotis K Thanos, Masanori Ichise, Victor W Pike, Robert B Innis, Ron D G McKay.   

Abstract

The derivation of dopamine neurons is one of the best examples of the clinical potential of embryonic stem (ES) cells, but the long-term function of the grafted neurons has not been established. Here, we show that, after transplantation into an animal model, neurons derived from mouse ES cells survived for over 32 weeks, maintained midbrain markers, and had sustained behavioral effects. Microdialysis in grafted animals showed that dopamine (DA) release was induced by depolarization and pharmacological stimulants. Positron emission tomography measured the expression of presynaptic dopamine transporters in the graft and also showed that the number of postsynaptic DA D(2) receptors was normalized in the host striatum. These data suggest that ES cell-derived neurons show DA release and reuptake and stimulate appropriate postsynaptic responses for long periods after implantation. This work supports continued interest in ES cells as a source of functional DA neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170065      PMCID: PMC4151324          DOI: 10.1634/stemcells.2006-0386

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  73 in total

Review 1.  Functional brain imaging in the differential diagnosis of Parkinson's disease.

Authors:  Paola Piccini; Alan Whone
Journal:  Lancet Neurol       Date:  2004-05       Impact factor: 44.182

2.  Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.

Authors:  R E Strecker; T Sharp; P Brundin; T Zetterström; U Ungerstedt; A Björklund
Journal:  Neuroscience       Date:  1987-07       Impact factor: 3.590

3.  In vivo comparative imaging of dopamine D2 knockout and wild-type mice with (11)C-raclopride and microPET.

Authors:  Panayotis K Thanos; Nicholas B Taintor; David Alexoff; Paul Vaska; Jean Logan; David K Grandy; Yuan Fang; Jing-Huei Lee; Joanna S Fowler; Nora D Volkow; Marcelo Rubinstein
Journal:  J Nucl Med       Date:  2002-11       Impact factor: 10.057

4.  The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.

Authors:  C R Gerfen; M Herkenham; J Thibault
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

5.  Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra.

Authors:  W J Freed; G N Ko; D L Niehoff; M J Kuhar; B J Hoffer; L Olson; H E Cannon-Spoor; J M Morihisa; R J Wyatt
Journal:  Science       Date:  1983-11-25       Impact factor: 47.728

Review 6.  Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.

Authors:  D J Brooks; K A Frey; K L Marek; D Oakes; D Paty; R Prentice; C W Shults; A J Stoessl
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330

7.  Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity.

Authors:  David L Alexoff; Paul Vaska; Douglas Marsteller; Timofei Gerasimov; Juan Li; Jean Logan; Joanna S Fowler; Nicholas B Taintor; Panayotis K Thanos; Nora D Volkow
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

8.  In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.

Authors:  T Zetterström; P Brundin; F H Gage; T Sharp; O Isacson; S B Dunnett; U Ungerstedt; A Björklund
Journal:  Brain Res       Date:  1986-01-08       Impact factor: 3.252

9.  Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.

Authors:  Margaret E Gnegy; Habibeh Khoshbouei; Kelly A Berg; Jonathan A Javitch; William P Clarke; Minjia Zhang; Aurelio Galli
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

10.  N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.

Authors:  Habibeh Khoshbouei; Namita Sen; Bipasha Guptaroy; L 'Aurelle Johnson; David Lund; Margaret E Gnegy; Aurelio Galli; Jonathan A Javitch
Journal:  PLoS Biol       Date:  2004-03-16       Impact factor: 8.029

View more
  43 in total

1.  SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.

Authors:  Julianna Kele; Emma R Andersson; J Carlos Villaescusa; Lukas Cajanek; Clare L Parish; Sonia Bonilla; Enrique M Toledo; Vitezslav Bryja; Jeffrey S Rubin; Akihiko Shimono; Ernest Arenas
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

2.  What can pluripotent stem cells teach us about neurodegenerative diseases?

Authors:  Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

3.  Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.

Authors:  Mianzhi Tang; J Carlos Villaescusa; Sarah X Luo; Camilla Guitarte; Simonia Lei; Yasunori Miyamoto; Makoto M Taketo; Ernest Arenas; Eric J Huang
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

4.  Tracking stem cell differentiation in the setting of automated optogenetic stimulation.

Authors:  Albrecht Stroh; Hsing-Chen Tsai; Li-Ping Wang; Feng Zhang; Jenny Kressel; Alexander Aravanis; Nandhini Santhanam; Karl Deisseroth; Arthur Konnerth; M Bret Schneider
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

5.  Estradiol promotes proliferation of dopaminergic precursors resulting in a higher proportion of dopamine neurons derived from mouse embryonic stem cells.

Authors:  Néstor F Díaz; Néstor E Díaz-Martínez; Ignacio Camacho-Arroyo; Iván Velasco
Journal:  Int J Dev Neurosci       Date:  2009-04-18       Impact factor: 2.457

6.  Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease.

Authors:  Rosario Sanchez-Pernaute; Hyojin Lee; Michaela Patterson; Casper Reske-Nielsen; Takahito Yoshizaki; Kai C Sonntag; Lorenz Studer; Ole Isacson
Journal:  Brain       Date:  2008-07-22       Impact factor: 13.501

7.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 8.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.

Authors:  Eva Hedlund; Jan Pruszak; Thomas Lardaro; Wesley Ludwig; Angel Viñuela; Kwang-Soo Kim; Ole Isacson
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

10.  Stem cells in development of therapeutics for Parkinson's disease: a perspective.

Authors:  Jiajie Xi; Su-Chun Zhang
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.